Literature DB >> 8296217

[Platelet neuropeptide Y and its vasoconstriction effect in rat].

Y F Yang1, L H Yang, G P Shi, Q D Han.   

Abstract

Specific radioimmunoassay showed that in rat neuropeptide Y (NPY) immuno-reactivities (IR) in platelets and platelet rich plasma (PRP) were respectively 90 +/- 16 ng/10(7) platelets and 93 +/- 19 ng/ml. Both values were much greater than those in the plasma (1.2 +/- 0.1 ng/ml, P < 0.001) and platelet poor plasma (PPP) (1.7 +/- 0.3 ng/ml, P < 0.001). The NPY-IR in rat platelets eluted at the same position as authentic NPY on reverse phase HPLC. The NPY-IR in the platelets prepared from the PRP aggregated maximally by collagen reduced to 34 +/- 5 ng/10(7) platelets, while the NPY-IR in the PPP prepared from the same PRP increased to 26 +/- 4 ng/ml. PPP 1.6 ml prepared from the aggregated PRP induced contraction of isolated rat caudal arteries with the maximal tension of 380 +/- 80 mg; while the maximal contraction induced by 1.6 ml of the same PPP pretreated with NPY anti-serum was only 190 +/- 40 mg (P < 0.001). Authentic NPY 1 nmol/L did not cause any contraction. The results indicate that rat platelets contain a high concentration of NPY, which can be released during irreversible platelet aggregation. The NPY released can potentiate vasoconstriction responses induced by co-released substances during platelet aggregation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8296217

Source DB:  PubMed          Journal:  Sheng Li Xue Bao        ISSN: 0371-0874


  1 in total

1.  Neuropeptide Y levels are associated with nutritional status and cardiovascular events in adults with chronic kidney disease.

Authors:  L Lu; Y-C Zou; M Wang; Y-F Huang; D-X Chen; L-B Wei
Journal:  Eur J Clin Nutr       Date:  2015-04-29       Impact factor: 4.016

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.